首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Susceptibilities of Mycobacterium marinum to Gatifloxacin Gemifloxacin Levofloxacin Linezolid Moxifloxacin Telithromycin and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones
【2h】

Susceptibilities of Mycobacterium marinum to Gatifloxacin Gemifloxacin Levofloxacin Linezolid Moxifloxacin Telithromycin and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones

机译:海水分枝杆菌对加替沙星吉米沙星左氧氟沙星利奈唑胺莫西沙星泰利霉素和奎奴普丁-达福普汀(Synercid)的敏感性与其对参考大环内酯和喹诺酮类药物的敏感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The susceptibility pattern of Mycobacterium marinum was determined. Quinupristin-dalfopristin and telithromycin were less active than clarithromycin. Linezolid showed good antimicrobial activity at clinically achievable concentrations. Gatifloxacin, levofloxacin, and moxifloxacin displayed activities similar to those of ciprofloxacin. Gemifloxacin was less active. The Etest method showed variable agreement with the reference method.
机译:确定了海洋分枝杆菌的敏感性模式。奎奴普丁-达福普汀和telithromycin的活性低于克拉霉素。利奈唑胺在临床上可达到的浓度下显示出良好的抗菌活性。加替沙星,左氧氟沙星和莫西沙星的活性与环丙沙星相似。吉米沙星活性较低。 Etest方法与参考方法显示出可变的一致性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号